Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
ASAssertio Holdings, Inc. logo

Assertio Holdings, Inc. (ASRT)

NASDAQ Capital Market · Currency in USD
$23.50 ▲ +0.00 (+0.00%)
At close: Jun 15, 4:00 PM ET. Market closed.
$23.49 ▼ -0.01 (-0.04%)
After hours: Jun 15, 7:18 PM ET

Summary

Previous Close
$23.50
Open
$23.48
Day's Range
$23.48 – $23.50
52 Week Range
$8.61 – $23.50
Volume
270,191
Avg. Volume
327,454
Market Cap
$151.86M
Beta (5Y Monthly)
0.53
PE Ratio (TTM)
--
EPS (TTM)
-$5.55
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$22.65

Profile: Assertio Holdings, Inc.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
58
CEO
Mark L. Reisenauer

Assertio Holdings, Inc. is a specialized pharmaceutical company focused on developing and commercializing therapeutic solutions across key medical domains, including neurology, hospital care, and pain and inflammation management. Among its portfolio, Assertio offers INDOCIN, available as both an oral solution and a suppository. This medication addresses conditions such as moderate to severe rheumatoid arthritis (including acute flare-ups), ankylosing spondylitis, osteoarthritis, acute painful shoulder, and gouty arthritis.

Earnings

DateEst.Actual
May 8, 2026-$1.91-$2.93Miss
Mar 16, 2026-$3.05-$1.86Beat
Nov 10, 2025-$1.28$1.65Beat
Aug 11, 2025-$1.35-$2.55Miss
May 12, 2025-$0.90-$2.10Miss
Mar 12, 2025-$0.05-$1.65Miss

Analyst view

Consensus price target
$22.65 ▼ -3.6%
Range $21.80 – $23.50
Rating: Hold
Buy 44% · Hold 50% · Sell 6%

Get free alerts on ASRT and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.